Pratik S Multani insider trades: Oric Pharmaceuticals (ORIC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pratik reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | ORIC | ↓ Sell | 10,720 | $9.06 | $97K | Direct | Dec 17, 2025 (1d) |
| Dec 16, 2024 | ORIC | ↓ Sell | 8,850 | $8.28 | $73K | Direct | Dec 17, 2024 (1d) |
| Dec 15, 2023 | ORIC | ↓ Sell | 5,282 | $8.59 | $45K | Direct | Dec 19, 2023 (4d) |
| Dec 15, 2022 | ORIC | ↓ Sell | 2,089 | $3.25 | $7K | Direct | Dec 16, 2022 (1d) |
| Jul 20, 2021 | ERAS | ↑ Buy | 6,200 | $16.00 | $99K | Direct | Jul 20, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORIC insiders
Open-market trades in the last 12 months
About Pratik S Multani's insider trades
Pratik S Multani is Chief Medical Officer at Oric Pharmaceuticals (ORIC). Since Jul 20, 2021, Pratik has reported 1 open-market purchase worth $99K and 4 sales worth $223K on SEC Form 4. In the last 12 months: 1 sale ($97K).
Their filings also include grants and awards (28 filings), option exercises (4 filings), shares returned to the company (3 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORIC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.